Cost-Effectiveness of Using NT-Pro B-Type Natriuretic Peptide in the Management of Acute Heart Failure in a Public Hospital

被引:0
|
作者
Kong, Tan Sian [1 ]
San, Leong Wen [3 ]
Yip, Alan Fong Yean [1 ]
Sieng, Phan Hui [2 ]
Kiam, Ong Tiong [1 ]
Hian, Sim Kui [1 ]
机构
[1] Sarawak Gen Hosp, Dept Cardiol, Kuching, Malaysia
[2] Sarawak Gen Hosp, Dept Pharmacol, Kuching, Malaysia
[3] Sultanah Aminah Hosp, Dept Cardiol, Johore Bharu, Malaysia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P667
引用
收藏
页码:E227 / E227
页数:1
相关论文
共 50 条
  • [21] B-type natriuretic peptide measurement in heart failure
    Spevack, DM
    Schwartzbard, A
    CLINICAL CARDIOLOGY, 2004, 27 (09) : 489 - 494
  • [22] B-type natriuretic peptide for congestive heart failure
    Wu, AHB
    JOURNAL OF CLINICAL LIGAND ASSAY, 2002, 25 (02): : 155 - 159
  • [23] Nonterminal pro B-type natriuretic peptide in patients with chronic heart failure: Correlation with B-type natriuretic peptide and left ventricular structure and function
    Mitrovic, V
    Anand, I
    Dill, T
    Weber, M
    Notter, T
    Schenk, J
    Luescher, TF
    Hamm, CW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 235A - 235A
  • [24] Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure
    Fonarow, Gregg C.
    Peacock, William F.
    Phillips, Christopher O.
    Givertz, Michael M.
    Lopatin, Margarita
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (19) : 1943 - 1950
  • [25] B-type natriuretic peptide as a marker for heart failure in patients with acute stroke
    Matthew A. Koenig
    H. Adrian Puttgen
    Vivek Prabhakaran
    Daniel Reich
    Robert D. Stevens
    Intensive Care Medicine, 2007, 33 : 1587 - 1593
  • [26] B-type natriuretic peptide as a marker for heart failure in patients with acute stroke
    Koenig, Matthew A.
    Puttgen, H. Adrian
    Prabhakaran, Vivek
    Reich, Daniel
    Stevens, Robert D.
    INTENSIVE CARE MEDICINE, 2007, 33 (09) : 1587 - 1593
  • [27] Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model
    Pufulete, Maria
    Maishman, Rachel
    Dabner, Lucy
    Mohiuddin, Syed
    Hollingworth, William
    Rogers, Chris A.
    Higgins, Julian
    Dayer, Mark
    Macleod, John
    Purdy, Sarah
    McDonagh, Theresa
    Nightingale, Angus
    Williams, Rachael
    Reeves, Barnaby C.
    HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (40) : 1 - +
  • [28] Cost-effectiveness of screening coronary artery disease patients with B-type natriuretic peptide
    Heidenreich, PA
    Bibbins-Domingo, K
    Pham, MX
    Whooley, MA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 422A - 422A
  • [29] Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure
    Griffin, Edward A.
    Wonderling, David
    Ludman, Andrew J.
    Al-Mohammad, Abdallah
    Cowie, Martin R.
    Hardman, Suzanna M. C.
    McMurray, John J. V.
    Kendall, Jason
    Mitchell, Polly
    Shote, Aminat
    Dworzynski, Katharina
    Mant, Jonathan
    VALUE IN HEALTH, 2017, 20 (08) : 1025 - 1033
  • [30] B-Type natriuretic peptide -: Current use in the diagnosis and management of heart failure
    Müller, C
    Kuster, G
    Büttner, HJ
    Buser, P
    HERZ, 2003, 28 (05) : 374 - 379